Pre-eclampsia (PE) is characterized by an exaggerated systemic inflammatory response and
Introduction
Pre-eclampsia (PE) is defined as pregnancy-induced hypertension associated with proteinuria that occurs after mid of pregnancy (Brown et al., 2001) . The etiology of PE remains unclear but a number of pathophysiologic mechanisms of the disorder have now been clarified. PE is characterized by increased circulating levels of the anti-angiogenic factor soluble fms-like tyrosine kinase-1 (sFLT-1) but suppressed levels of the pro-angiogenic factors free vascular endothelial growth factor (VEGF) and placental growth factor (PIGF) (Widmer et al., 2015) . Increased levels of circulating markers of endothelial cell damage such as vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1) have also been described (Veas et al., 2011 , Prochazka et al., 2015 . Altered activation and function of circulating inflammatory cells such as monocytes (Sibai, 2004 , Alofi et al., 2012 as well as a changes in their subpopulations, and exaggerated responses to toll-like receptor (TLR) 2 and 4 ligands have been described (Al-ofi et al., 2012) . All of these observations suggest that vascular endothelial cell dysfunction and altered immunological responses play major roles in the pathogenesis of PE.
It has been recognized that the interaction between peripheral blood monocytes and vascular endothelial cells alters the expression of various inflammatory mediators: the co-culture of monocytes with endothelial cells has been shown to induce more inflammatory markers (such as IL-6, IL-1β, IL-1α, IL-8, MCP-1, IFN γ-inducible protein 10, and granulocytemacrophage colony-stimulating factor, GM-CSF) and adhesion molecules than the monoculture of either cell type individually (Lukacs et al., 1995 , Takahashi et al., 1996 , Kasama et al., 2002 , Ward et al., 2009 . Monocytes appear to play key roles in the regulation of endothelial cell proliferation and survival, as well as angiogenesis, (Schubert et al., 2011) . Furthermore, they are activated in PE, as shown by us (Al-ofi et al., 2012) and others (Gervasi et al., 2001, Luppi and Deloia, 2006) . For example, CD11 and reactive oxygen species are upregulated in PE monocytes (Gervasi et al., 2001) .
Fibrinogen, an endogenous ligand of TLR4 is also able to bind and activate the signaling of immune cells (i.e. monocytes) via CD11b/CD18 integrin receptors and adhesion molecules (Hodgkinson et al., 2008) . During normal pregnancy, plasma fibrinogen is increased and fibrinolysis activity is suppressed, ostensibly to promote coagulability of blood (Thornton and Douglas, 2010) . There are conflicting data regarding fibrinogen levels in PE, with some studies, including ours, demonstrating increased (Al-ofi et al., 2014 , Kawada, 2015 , whilst others demonstrate reduced, circulating levels (Spiezia et al., 2015) . Moreover, immunofluorescence microscopy has revealed fibrin deposition in the vascular compartments 4 of the placenta, kidney and liver in severe PE (Arias and Mancilla-Jimenez, 1976 , Roberts and Post, 2008 , Al-ofi et al., 2014 We recently showed that fibrinogen activates monocytes from women with PE (Al-ofi et al., 2014) . We therefore postulated that fibrinogen-induced activation of "inflammatory" monocytes in PE could impair vascular endothelial cell function and alter their chemoattractant, angiogenic and inflammatory responses, thus playing a key role in the pathogenesis of PE. We tested this hypothesis by comparing the responses to fibrinogen and LPS of HUVECs co-incubated with PE monocytes to the responses of HUVECs co-incubated with monocytes from normotensive women matched for gestation. We chose fibrinogen and HMGB1 as the endogenous ligands of TLR4 having demonstrated in an earlier study that, of the TLR4 ligands studied, fibrinogen was the only factor that appeared to induce inflammatory cytokine release from PE monocyte cultures (Al-ofi et al., 2014) . Our co-culture experimental model enabled us to determine the effects of these TLR4 ligands on the expression levels of inflammatory cytokines (IL-6 and IL-1β), chemokines (IL-8 and MCP-1), angiogenic (VEGF) and anti-angiogenic (sFLT-1) factors, as well as the cell adhesion molecule sVCAM-1.
Material and Method

Ethical approval
Ethical approval for this study was received from the South Yorkshire Research Ethics Committee (09/H1310/12). A detailed information sheet was given to all study participants and written informed consent was obtained from them.
Subjects and samples
Consent for use of umbilical cords was obtained from term normotensive pregnant women in early labour in the delivery suite of the Jessop Wing Hospital (n=12). The harvested umbilical cords were used for the isolation of HUVECs. Monocytes were obtained from blood samples from nine women with PE and nine NP women (Table1), and used for HUVEC co-culture experiments. 10ml of fresh blood was collected into a tube containing EDTA to prevent clotting and immediately transported to the research laboratories to isolate monocytes for the experiments.
Stimulation of monocytes and HUVEC cultures
Co-culture experiments of primary human monocytes and endothelial cells were optimized according to previously published studies (Schubert et al., 2008 , Ward et al., 2009 . Human vascular endothelial cells were isolated from freshly collected umbilical cords using standard published techniques (Baudin et al., 2007) . The HUVECs were then cultured and studied on the second through fifth passages. HUVECs were seeded onto 0.2% gelatin-coated 12-well tissue-culture plates (Greiner bio-one, catalogue number: 665180) at a density of 10 5 cells per well and incubated with one ml of medium (DMEM supplemented with 10% heatinactivated FBS, 2 mM L-Glutamine and penicillin-streptomycin) at 37°C with 5% CO2 until they reached 70-90% of confluence, usually within two to three days. The day before the experiment, the cells were washed with 1ml of pre-warmed PBS and cultured with low serum media (DMEM supplemented with 5% heat inactivated FBS without antibiotics) for serum starvation.
The monocytes were isolated from the fresh blood of donors (NP or PE), collected in EDTA tubes and separated immediately after the blood was drawn. HUVECs were cultured separately with the equivalent density (mono-cultures). Mono-culture and co-culture assays were performed in DMEM with 5% heat-inactivated FBS without antibiotics media. Thereafter, mono-and co-cultures were immediately stimulated with 100 ng/ml lipopolysaccharides (rough strains) from Escherichia coli EH 100 (Sigma-Aldrich), 5 μg/ml peptidoglycan from Staphylococcus aureus (Sigma-Aldrich), 2 mg/ml fibrinogen from human plasma (Sigma-Aldrich), and 0.7 μg/ml recombinant human HMGB1 (R and D Systems), as described in previous studies (Smiley et al., 2001 , Yu et al., 2006 , by 24h of incubation at 37°C with 5% CO2. After 24h, the conditioned medium was collected and stored at -80°C.
Flow cytometry
Flow cytometry was used to confirm the presence of monocyte and endothelial cell populations in the co-culture experimental models as depicted in the Fig 1.
Cytometric bead array
The cytometric bead array (CBA) technique was used to measure the inflammatory cytokines (IL-1 and IL-6), the anti-inflammatory cytokine (IL-10), and chemokines (IL-8 and MCP-1) within conditioned medium collected from monocytes and the HUVECs cultures. This assay was performed as previously described using kits from BD Biosciences, a BD FACS Array flow cytometry machine and FCAP Array software. The IL-1 and IL-10 cytokines were measured in the undiluted aliquot (30μl). However, IL-6, IL-8 and MCP-1 cytokines were above standard levels for undiluted aliquots. Consequently, serial dilutions (1:10 up to 1:200)
were attempted to optimize the desired dilution. Thereafter, according to the optimum concentration within the sample, either 1:50 or 1:100 dilutions were applied to the samples, and each sample was multiplied according to its dilution factor before analysis was initiated.
Additionally, The CBA technique was used to measure the VEGF and sVCAM-1 in the supernatant medium collected from monocytes-HUVECs mono-or co-cultures.
Enzyme-linked Immunosorbent Assay
Human sVEGFR-1 / sFLT-1 Immunoassay (Quantikine ELISA kit catalogue number:
DVR100B, R&D Systems, Europe) was used for the quantitative determination of human sFLT-1 concentrations in cell culture supernatants. All measurements were made in triplicate on 1:5 dilutions of the culture media.
Statistical analysis
The results are illustrated as mean ± standard error of the mean (SEM). One-way ANOVA (Kruskal-Wallis test), followed by correction using Dunn's multiple comparisons test, was used to compare differences between mono-cultures of HUVECs and monocytes, as well as between co-cultures of NP/PE monocytes and HUVECs, using GraphPad Prism software version 7.0. The two-way ANOVA test was used to compare differences between the unstimulated cells and the cells stimulated with different agonists (bacterial and endogenous ligands of TLRs). P values < 0.05 were considered significantly different.
Results
Monocytes of women with PE alter inflammatory responses of vascular endothelial cells in co-culture experimental model (Figure 2)
In comparison with NP co-cultures, unstimulated co-cultures of PE monocytes with endothelial cells demonstrated profoundly increased secretion of the inflammatory cytokine IL-6 (P<0.05) as well as the chemokines IL-8 and MCP-1 (Fig 2A, 2D and 2E respectively) (P<0.01), along with reduced production of the anti-inflammatory cytokine IL-10 (Fig 2C) .
Additionally, unstimulated monocyte-HUVEC co-cultures from NP and PE groups released significantly higher IL-6 levels than monocyte monocultures; IL-6 expression from HUVEC-PE monocyte co-cultures was more than 10-fold higher than from PE monocyte monocultures (P<0.05) (Fig 2A) . Furthermore, HUVEC-PE monocyte co-cultures produced much higher basal levels of IL-8 than PE monocyte monocultures (P<0.05) (Fig 2D) . Basal expression levels of IL-1β and IL-10 did not differ between PE mono-and co-cultures ( Fig 2B   and 2C respectively) . HUVECs and NP/PE monocytes in monocultures did not produce MCP-1. Conversely, when both cell types interacted during co-cultures experiments, there was a significant increase in MCP-1 production, especially from HUVEC-PE monocyte cocultures (P<0.001) (Fig 2E) .
Fibrinogen alters inflammatory responses of monocytes from women with PE cocultured with vascular endothelial cells (Figure 3)
After stimulation with LPS, IL-6 significantly increased in both NP and PE co-culture models (P<0.05 and P<0.001) (Fig 3A) . Compared with NP, TLR bacterial ligand-treated HUVEC-PE monocyte co-cultures exhibited markedly increased IL-6 secretion, compared to that seen in ligand-treated HUVEC-NP monocytes (P<0.01). In contrast, endogenous ligands of TLR4 evoked no such increase in NP as well as PE monocyte co-cultures.
LPS, PDG, and fibrinogen significantly induced IL-1β secretion by PE monocytes, with or without HUVECs, when compared to the non-stimulated control (P<0.05 and P<0.001) ( Fig   3B) . Additionally, LPS and PDG significantly induced IL-1β in HUVEC-NP monocytes when compared to non-stimulated control (P<0.05). Fibrinogen-treated HUVEC-PE monocytes exhibited a marked increase in IL-1β secretion compared to fibrinogen-treated HUVEC-NP monocytes (P<0.05). However, unlike IL-6 and IL-β, IL-10 expression levels did not differ between ligand-treated HUVEC-monocyte co-cultures from PE and NP groups (Fig 3C) .
Compared to non-stimulated-HUVEC-PE monocyte co-cultures, LPS and PDG induced IL-8 secretion whilst fibrinogen appeared to suppress it and HMGB1 did not alter its basal secretion ( Fig 3D) . In contrast, all ligands significantly induced IL-8 in HUVEC-NP monocyte co-cultures compared to un-stimulated co-cultures (P<0.05).
Compared to non-stimulated controls, MCP-1 was released in large amounts from PDGtreated HUVEC-PE monocyte co-cultures (P<0.001); was not produced by LPS-treated HUVEC-PE monocyte co-cultures; and was suppressed in fibrinogen-HUVEC-PE monocyte co-cultures (Fig 3E) . 8
Fibrinogen attenuates sFLT-1-induced dys-angiogenesis (Figure 4)
Human vascular endothelial cell monocultures produced high basal levels of sFLT-1.
However, this appeared down-regulated by co-culture with monocytes from both groups of pregnant women (P<0.001), NP monocytes more so than PE monocytes (P<0.05) (Fig 4A1) .
Although the treatment of HUVEC monocultures with LPS or PDG appeared to reduce sFLT-1 production, this observation did not attain statistical significance (Fig 4A2) . On the other hand, stimulation of co-cultures with bacterial ligands induced sFLT-1 production in both NP and women with PE ( Fig 4A2) . Fibrinogen treatment of HUVEC-PE monocyte co-cultures significantly reduced sFLT-1 production (Fig 4A2) (P<0.001) but did not alter sFLT-1 production by HUVEC-NP monocytes co-culture (Fig 4A2) .
The basal expression levels of VEGF differed significantly between the various culture models as depicted in Fig 4B1. HUVEC monocultures expressed relatively higher levels of VEGF than HUVEC with NP or PE monocyte co-cultures ( Fig 4B1) . Stimulation of mono or co-cultures with TLR ligands did not result in altered VEGF production, except for HMGB1 which appeared to induce production in by PE monocytes in culture (P<0.05) (Fig 4B2) .
Fibrinogen enhanced vascular adhesion in PE (Figure 4C)
We also determined that soluble vascular cell adhesion molecule is induced by the interaction between monocytes from women with PE and vascular endothelial cells. As depicted in (Fig 4C1) , HUVECs and NP/PE monocytes in monocultures produced very low levels of VCAM-1. However, cell-cell interactions during co-cultures experiments resulted in significant increases in VCAM-1 production, especially from HUVEC-PE monocytes cocultures (P<0.001) (Fig 4C1) . Unstimulated HUVECs produced extremely low levels of VCAM-1. However, LPS, but not other TLR ligands, induced higher expression levels of VCAM-1 (P<0.05) (Fig 4C2) . Compared to the HUVEC-NP monocyte co-culture, the HUVEC-PE monocyte co-culture was associated with higher basal expression levels of VCAM-1 (P<0.05) (Fig 4C1) , and an exaggerated VCAM-1 response on exposure to TLR bacterial ligands was also associated with (P<0.05) (Fig 4C2) . Furthermore, the HUVEC-PE monocyte co-culture exhibited amplified VCAM-1 secretion in response to fibrinogen compared to the HUVEC-NP monocyte co-culture (P<0.001) (Fig 4C2) .
Discussion
This study develops on our previous observation that fibrinogen, an endogenous ligand of TLR4, appears to induce PE monocytes to release inflammatory cytokines (Al-ofi et al., 2014) , consistent with several studies that suggest a role for this receptor in the pathogenesis of PE (Al-ofi et al., 2012 , Chen et al., 2015 , Kulikova et al., 2016 . We now show that fibrinogen also appears to suppress the expression of inflammatory cytokine markers, induce the expression of cell adhesion molecules, and promote angiogenesis (by decreasing sFLT-1 production) when PE monocytes and endothelial cells are established in co-culture.
To the best of our knowledge, this is the first study to report the influence of activated human peripheral blood monocytes from patients with PE on endothelial cell function. We successfully established a co-culture model of human primary peripheral blood monocytes and HUVECs, and showed that PE monocytes in co-culture with HUVECs elaborated more IL-6 (pro-inflammatory cytokine), IL-18 and MCP-1 (chemokines) compared to NP monocyte-HUVECS co-cultures, whereas the anti-inflammatory cytokine IL-10 expression levels was attenuated.
Several studies have shown that IL-6 levels are elevated in the plasma of women with preeclampsia and is involved in the pathogenesis of the condition (Freeman et al., 2004 , Jonsson et al., 2006 , Xiao et al., 2012 . Being a multifunctional cytokine, IL-6 could play a key role in the modulation of angiogenesis in normotensive or hypertensive pregnancy (Desai et al., 2002) . We have observed the elevation of IL-6 levels when HUVECs are established in co-culture with monocytes from women with PE, suggesting that IL-6 may promote vascular endothelial dysfunction in PE. Similarly, bacterial TLR2 and TLR4 ligands induced very high levels of IL-6 in co-cultures of PE monocytes with HUVECs, suggesting that vascular endothelial damage in PE may involve TLR-mediated mechanisms. It is intriguing that fibrinogen appeared to induce IL-6 production from monocultures of PE, but not NP monocytes (consistent with our previous report (Al-ofi et al., 2014) ), but reduced its release from PE monocyte-HUVECs co-cultures. The potential mechanism of this observation is unclear but it seems plausible that monocyte release of IL-6 in the presence of fibrinogen may be altered by the presence of endothelial cells in the microvasculature. It is plausible that there is potential gene-gene association between IL-6 and fibrinogen, which could influence fibrinogen levels without influencing the development of cardiovascular disease (Carty et al., 2010) . It may also be that fibrinogen at this interface regulates monocyte activation and the release of cytokines in order to protect endothelial cells from inflammatory damage.
It has been shown in porcine and murine models of vascular disease, and through in vitro experiments employing co-cultures of primary human monocytes and endothelial cell, that IL-1β is a critical mediator of vascular inflammation (Morton et al., 2005 , Chamberlain et al., 2006 , Ward et al., 2009 . Data from the current study demonstrate that fibrinogen significantly induced IL-1β production by PE monocytes in mono-as well as co-cultures with HUVECs, compared to NP monocytes. In another study, IL-1β, but not IL-1α, binds to fibrinogen and augments endothelial cell activity with increased NF-kβ, MCP-1, and nitric oxide production (Sahni et al., 2004) . It is plausible that impairment of such binding in PE may lead to an increase of free IL-1β that modulates further vascular inflammation. IL-8 is a chemo-attractant for neutrophils and T cells, as well as a potent angiogenic marker (Koch et al., 1992) , whilst MCP-1 is a chemo-attractant for mononuclear leukocytes (Leonard and Yoshimura, 1990) . Kauma et al., demonstrated that plasma of women with severe PE expressed higher levels of IL-8 and MCP-1, and induced HUVEC to release IL-8 and MCP-1 (Kauma et al., 2002) . We have observed increased chemokine production from NP monocyte-HUVEC co-cultures, indicating their role in normal angiogenesis. Their amplified production from PE monocyte-HUVEC co-cultures is consistent with dysregulated angiogenesis in this model. The apparent modulatory effect of fibrinogen on the production of IL-8 from PE monocyte-HUVEC co-cultures suggests some role for fibrinogen during chemotaxis. MCP-1 production appeared amplified in PDG-treated HUVEC-PE monocyte cocultures, but reduced in fibrinogen-treated PE monocyte-HUVEC co-cultures. Taken together, our data suggest a complex role for TLR-2 and -4 receptors, and their ligands, in vascular endothelial homeostasis in PE, which merits further investigation.
Circulating sFLT-1 is an anti-angiogenic protein whose levels are increased in PE, a condition in which it appears to suppress circulating PIGF and VEGF (Maynard et al., 2003 , Chappell et al., 2013 , Widmer et al., 2015 . We have demonstrated that endothelial cells produced higher basal levels of sFLT-1, consistent with previous studies (Kendall et al., 1996 , Barleon et al., 2001 . For the first time however, we show that sFLT-1 production by HUVECs can be inhibited by fibrinogen. At variance with a previous study that reported that peripheral blood monocytes were capable of producing sFLT-1, and that this production was enhanced by LPS stimulation (Barleon et al., 2001) , our results showed undetectable sFLT-1 release from PE or NP monocyte mono-cultures, even after TLR2 or TLR4 stimulation. One explanation for the differences between these studies could be the differing duration of culturing the monocytes -we incubated monocytes for 24 hours whilst Barleon et al (Barleon et al., 2001 ) did so for 72 hours. We also observed that monocytes from both pregnant groups attenuated sFLT-1 production by endothelial cells, but that PE monocytes did not appear to suppress its release to the same degree as NP monocytes. Although the LPS-or PDG-treated NP/PE co-cultures induced sFLT-1 production, an intriguing finding is that fibrinogen suppressed sFLT-1 production in the HUVEC-PE monocyte but not in the HUVEC-NP monocyte co-culture. The plausible explanation for this observation is unclear but a role for fibrinogen in counteracting dysregulated angiogenesis in PE seems likely. We observed reduced soluble VEGFR-1 (sFLT-1) from HUVEC or HUVEC-PE monocyte co-cultures, in agreement with one study that shows that endothelial cells cultured on fibrin matrices had markedly reduced growth factor receptors; particularly FGFR-1, FGFR-2 and VEGFR-1 (Tsou and Isik, 2001) . Taken together, in addition to its well-established role in vascular haemostasis, our observations suggest that fibrinogen may contribute to endothelial repair in PE by enhancing angiogenesis through mechanisms that may include suppression of sFLT-1 production.
Furthermore, our result demonstrated reduced levels of VEGF in PE monocytes-HUVECs coculture compared to NP, confirming previous reports of increased sFlt-1 and reduced VEGF in PE (Lam et al., 2005) . One unanticipated finding was that HMGB-1 treatment of the PE monocytes monoculture induced VEGF production whilst other TLR ligands did not. This may be because HMGB-1 appears to stimulate VEGF production from PE monocytes through a different signalling pathway, such as the advanced glycation end product (RAGE) (Huang et al., 2010) , as has been shown in oesophageal squamous cell carcinoma (Chen et al., 2012) .
Soluble adhesion molecules (VCAM-1, ICAM-1 and E-selectin) are elevated in the serum of patients with PE (Sibai, 2004 , Al-ofi et al., 2012 . Serum from women with PE also activates endothelial cells to express ICAM-1 but only in the presence of monocytes (Faas et al., 2010) .
Consistent with these previous studies (Sibai, 2004 , Faas et al., 2010 , Al-ofi et al., 2012 , we observed increased expression levels of VCAM-1 by HUVEC-PE monocyte co-culture, and further enhanced induction by the bacterial TLR2/4 ligands (LPS and PDG) as well as by fibrinogen. Languino et al. inferred from their studies that fibrinogen acts as a molecular bridge between endothelial cells and leukocytes, enhancing the adhesion of leukocytes to the vascular endothelium and facilitating leukocyte trans-endothelial migration (Languino et al., 1995) . The fibrinogen-ICAM-1 interaction is associated with activation of MMPs and the digestion of junction proteins, thus disrupting endothelial layer integrity and increasing vascular permeability (Lominadze et al., 2010) . Moreover, fibrinogen stimulates TLR4 signalling in macrophages to release MMP-1 and MMP-9 (Hodgkinson et al., 2008) .
Fibrinogen seems to accumulate in the sub-endothelium at the site of vascular injury and may then act as matrices over which endothelial cells could attach, proliferate and spread (Lominadze et al., 2010) .
Conclusion
We have shown that fibrinogen and HMGB1 variably induce pro-inflammatory cytokine production in co-cultures of monocytes and HUVECs similar to, but less strongly than, the TLR2 and TL4 ligands peptidoglycan and lipopolysaccharide. Our observations suggest that fibrinogen appears to promote monocyte-endothelial cell adhesion thus may contribute to endothelial repair in PE by promoting angiogenesis through unknown mechanisms that may include strong suppression of sFLT-1 production. How fibrinogen modulates cell adhesion, angiogenesis and inflammation in normotensive and hypertensive pregnancy, and whether these functions are mediated by the TLR4 receptor or other fibrinogen receptors remain to be determined.
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